E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/29/2012 in the Prospect News PIPE Daily.

Biorem to sell C$1.5 million of debenture units via private placement

Proceeds of deal used for working capital, general corporate purposes

By Devika Patel

Knoxville, Tenn., June 29 - Biorem Inc. said it priced a C$1.5 million private placement of convertible debenture units.

The company will sell 1,500 units of a C$1,000 convertible extendible secured subordinated debenture and 4,545 warrants at C$1,000 per unit.

The 8% convertible debentures mature in two years and will be convertible into common stock at a conversion price of C$0.11 per share, which is a 10% premium to the June 28 closing price of C$0.10.

The debentures' maturity may be extended and may be prepaid.

Each warrant is exercisable at C$0.11 for two years. The strike price also reflects a 10% premium to the June 28 closing share price.

Insiders may participate for more than 25% of the placement.

Proceeds will be used for working capital and general corporate purposes.

Biorem, based in Guelph, Ont., manufactures technologies used to filter air in municipal and industrial applications.

Issuer:Biorem Inc.
Issue:Units of a C$1,000 convertible extendible secured subordinated debenture and 4,545 warrants
Amount:C$1.5 million
Units:1,500
Price:C$1,000
Maturity:Two years
Coupon:8%
Conversion price:C$0.11
Conversion premium:10%
Call:Yes
Warrants:4,545 warrants per unit
Warrant expiration:Two years
Warrant strike price:C$0.11
Pricing date:June 29
Stock symbol:TSX Venture: BRM
Stock price:C$0.10 at close June 28
Market capitalization:C$1.23 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.